Advertisement

Journal of Assisted Reproduction and Genetics

, Volume 30, Issue 9, pp 1147–1156 | Cite as

Coenzyme Q10 and male infertility: a meta-analysis

  • Rafael Lafuente
  • Mireia González-Comadrán
  • Ivan Solà
  • Gemma López
  • Mario Brassesco
  • Ramón Carreras
  • Miguel A. Checa
Gonadal Physiology and Disease

Abstract

Objective

To evaluate the effect of coenzyme Q10 treatments in male infertility, specifically in these parameters: live birth and pregnancy rates, CoQ10 seminal concentration, sperm concentration, and sperm motility.

Materials and methods

Systematic review and meta-analysis in male infertility patients with CoQ10 oral treatments. Three trials were included: 149 males in CoQ10 group and 147 males in placebo group.

Results

None of the included trials provided any data regarding live births. The results of this meta-analysis show that supplementing infertile men with CoQ10 does not increase pregnancy rates. The analysis showed, among patients receiving CoQ10 treatment, a statistically significant increase in: CoQ10 seminal concentration (RR 49.55, 95 % CI 46.44 to 52.66, I2 = 17 %), sperm concentration (RR 5.33, 95 % CI 4.18 to 6.47, I2 = 58 %), and sperm motility (RR 4.50, 95 % CI 3.92 to 5.08, I2 = 0 %)

Conclusion

There is no evidence in the literature that CoQ10 increases either live birth or pregnancy rates, but there is a global improvement in sperm parameters. Adequately powered, robust trials of individual and combination antioxidant therapies are required to guide clinical practice.

Keywords

Coenzyme Q10 Male infertility Randomized controlled trial Live birth 

Notes

Conflict of interest

The authors declare no conflict of interest.

Financial support

None

References

  1. 1.
    Agarwal A, Saleh RA, Bedaiwy MA. Role of reactive oxygen species in the pathophysiology of human reproduction. Fertil Steril. 2003;79:829–43.PubMedCrossRefGoogle Scholar
  2. 2.
    Agarwal A, Said TM. Carnitines and male infertility. Reprod Biomed Online. 2004;8(4):376–84. Review.PubMedCrossRefGoogle Scholar
  3. 3.
    Aitken RJ, Clarkson JS, Fishel S. Generation of reactive oxygen species, lipid peroxidation and human sperm function. Biol Reprod. 1989;40:183–97.CrossRefGoogle Scholar
  4. 4.
    Alleva R, Scararmucci A, Mantero F, Bompadre S, Leoni L, Littarru GP. The protective role of ubiquinol-10 against formation of lipid hydroperoxides in human seminal fluid. Mol Aspects Med. 1997;18(Suppl):S221–8.PubMedCrossRefGoogle Scholar
  5. 5.
    Auger J, Eustache F, Andersen AG, Irvine DS, Jorgensen N, Skakkebaek NE, et al. Sperm morphological defects related to environment, lifestyle and medical history of 1001 male partners of pregnant women from four European cities. Hum Reprod. 2001;16:2710–7.PubMedCrossRefGoogle Scholar
  6. 6.
    Balercia G, Armeni T, Mantero F, Principato G, Regoli F. Total oxyradical scavenging capacity toward different reactive oxygen species in seminal plasma and sperm cells. Clin Chem Lab Med. 2003;41(1):13–9.PubMedCrossRefGoogle Scholar
  7. 7.
    Balercia G, Buldreghini E, Vignini A, Tiano L, Paggi F, Amoroso S, et al. Coenzyme Q10 treatment in infertile men with idiopathic asthenozoospermia: a placebo-controlled, double-blind randomized trial. Fertil Steril. 2009;91(5):1785–92.PubMedCrossRefGoogle Scholar
  8. 8.
    Balercia G, Mancini A, Paggi F, Tiano L, Pontecorvi A, Boscaro M, et al. Coenzyme Q10 and male infertility. J Endocrinol Invest. 2009;32(7):626–32. Review.PubMedGoogle Scholar
  9. 9.
    Cavallini G, Ferraretti AP, Gianaroli L, Biagiotti G, Vitali G. Cinnoxicam and L-carnitine/acetyl-L-carnitine treatment for idiopathic and varicocele-associated oligoasthenospermia. J Androl. 2004;25(5):761–70.PubMedGoogle Scholar
  10. 10.
    Comhaire FH, Christophe AB, Zalata AA, Dhooge WS, Mahmoud AM, Depuydt CE. The effects of combined conventional treatment, oral antioxidants and essential fatty acids on sperm biology in subfertile men. Prostaglandins Leukot Essent Fat Acids. 2000;63(3):159–65.CrossRefGoogle Scholar
  11. 11.
    Comhaire FH, El Garem Y, Mahmoud A, Eertmans F, Schoonjans F. Combined conventional/antioxidant “Astaxanthin” treatment for male infertility: a double blind, randomized trial. Asian J Androl. 2005;7(3):257–62.PubMedCrossRefGoogle Scholar
  12. 12.
    Dawson EB, Harris WA, Teter MC, Powell LC. Effect of ascorbic acid supplementation on the sperm quality of smokers. Fertil Steril. 1992;58(5):1034–9.PubMedGoogle Scholar
  13. 13.
    Eskenazi B, Kidd SA, Marks AR, Sloter E, Block G, Wyrobek AJ. Antioxidant intake is associated with semen quality in healthy men. Hum Reprod. 2005;20(4):1006–12.PubMedCrossRefGoogle Scholar
  14. 14.
    Farquharson RG, Jauniaux E, Exalto N, ESHRE Special Interest Group for Early Pregnancy (SIGEP). Updated and revised nomenclature for description of early pregnancy events. Hum Reprod. 2005;20(11):3008–11.PubMedCrossRefGoogle Scholar
  15. 15.
    Fleiss JL. The statistical basis of meta-analysis. Stat Methods Med Res. 1993;2(2):121–45. Review.PubMedCrossRefGoogle Scholar
  16. 16.
    Fraga CG, Motchnik PA, Shigenaga MK, Helbock HJ, Jacob RA, Ames BN. Ascorbic acid protects against endogenous oxidative DNA damage in human sperm. Proc Natl Acad Sci U S A. 1991;88(24):11003–6.PubMedCrossRefGoogle Scholar
  17. 17.
    Fraga CG, Motchnik PA, Wyrobek AJ, Rempel DM, Ames BN. Smoking and low antioxidant levels increase oxidative damage to sperm DNA. Mutat Res. 1996;351(2):199–203.PubMedCrossRefGoogle Scholar
  18. 18.
    Ford WC, Whittington K. Antioxidant treatment for male subfertility: a promise that remains unfulfilled. Hum Reprod. 1998;13(6):1416–9.PubMedCrossRefGoogle Scholar
  19. 19.
    Geva E, Bartoov B, Zabludovsky N, Lessing JB, Lerner-Geva L, Amit A. The effect of antioxidant treatment on human spermatozoa and fertilization rate in an in vitro fertilization program. Fertil Steril. 1996;66(3):430–4.PubMedGoogle Scholar
  20. 20.
    Groneberg DA, Kindermann B, Althammer M, Klapper M, Vormann J, Littarru GP, et al. Coenzyme Q10 affects expression of genes involved in cell signalling, metabolism and transport in human CaCo-2 cells. Int J Biochem Cell Biol. 2005;37(6):1208–18.PubMedCrossRefGoogle Scholar
  21. 21.
    Higgins JPT, Thompson SG, Deeks JJ, Altman DG. Measuring inconsistency in meta-analyses. BMJ. 2003;327(7414):557–60.PubMedCrossRefGoogle Scholar
  22. 22.
    Higgins JPT, Green S. Cochrane Handbook for Systematic Reviews of Interventions. Versio 5.1.0. The Cochrane Collaboration, 2011. Available from http://handbook.cochrane.org
  23. 23.
    Johnson L, Varner DD. Effect of daily spermatozoan production but not age on transit time of spermatozoa through the human epididymis. Biol Reprod. 1988;39(4):812–7.PubMedCrossRefGoogle Scholar
  24. 24.
    Kessopoulou E, Powers HJ, Sharma KK, Pearson MJ, Russell JM, Cooke ID, et al. A double-blind randomized placebo cross-over controlled trial using the antioxidant vitamin E to treat reactive oxygen species associated male infertility. Fertil Steril. 1995;64(4):825–31.PubMedGoogle Scholar
  25. 25.
    Lanzafame FM, La Vignera S, Vicari E, Calogero AE. Oxidative stress and medical antioxidant treatment in male infertility. Reprod Biomed Online. 2009;19(5):638–59. Review.PubMedCrossRefGoogle Scholar
  26. 26.
    Lenzi A, Picardo M, Gandini L, Dondero F. Lipids of the sperm plasma membrane: from polyunsaturated fatty acids considered as markers of sperm function to possible scavenger therapy. Hum Reprod Update. 1996;2(3):246–56. Review.PubMedCrossRefGoogle Scholar
  27. 27.
    Lenzi A, Lombardo F, Sgrò P, Salacone P, Caponecchia L, Dondero F, et al. Use of carnitine therapy in selected cases of male factor infertility: a double-blind crossover trial. Fertil Steril. 2003;79(2):292–300.PubMedCrossRefGoogle Scholar
  28. 28.
    Lenzi A, Sgrò P, Salacone P, Paoli D, Gilio B, Lombardo F, et al. A placebo-controlled double-blind randomized trial of the use of combined l-carnitine and l-acetyl-carnitine treatment in men with asthenozoospermia. Fertil Steril. 2004;81(6):1578–84.PubMedCrossRefGoogle Scholar
  29. 29.
    Littarru GP, Tiano L. Bioenergetic and antioxidant properties of coenzyme Q10: recent developments. Mol Biotechnol. 2007;37(1):31–7. Review.PubMedCrossRefGoogle Scholar
  30. 30.
    Littarru GP, Tiano L. Clinical aspects of coenzyme Q10: an update review. Nutrition. 2010;26(3):250–4.PubMedCrossRefGoogle Scholar
  31. 31.
    López G, Lafuente R, Checa MA, Monqaut A, Brassesco M. Effect of a treatment with vitamins, L-carnitine and coenzyme Q10 on sperm head vacuolization and DNA fragmentation on in vitro fertilization patients. Rev Int Androl. 2011;09(4):154–9.Google Scholar
  32. 32.
    Moher D, Liberati A, Tetzlaff J, Altman DG. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. BMJ. 2009;339:b2535.PubMedCrossRefGoogle Scholar
  33. 33.
    Nadjarzadeh A, Sadeghi MR, Amirjannati N, Vafa MR, Motevalian SA, Gohari MR, et al. Coenzyme Q10 improves seminal oxidative defense but does not affect on semen parameters in Idiopathic Oligoasthenoteratozoospermia: a Randomized Double-blind, placebo Controlled Trial. J Endocrinol Invest 2011; e224-e228.Google Scholar
  34. 34.
    Rao B, Soufir JC, Martin M, David G. Lipid peroxidation in human spermatozoa as related to midpiece abnormalities and motility. Gamete Res. 1989;24:127–34.PubMedCrossRefGoogle Scholar
  35. 35.
    Ross C, Morriss A, Khairy M, Khalaf Y, Braude P, Coomarasamy A, et al. A systematic review of the effect of oral antioxidants on male infertility. Reprod Biomed Online. 2010;20(6):711–23.PubMedCrossRefGoogle Scholar
  36. 36.
    Safarinejad MR. Efficacy of coenzyme Q10 on semen parameters, sperm function and reproductive hormones in infertile men. J Urol. 2009;182:237–48.PubMedCrossRefGoogle Scholar
  37. 37.
    Sheweita S, Tilmisany A, Al-Sawaf H. Mechanisms of male infertility: role of antioxidants. Curr Drug Metab. 2005;6(5):495–501.PubMedCrossRefGoogle Scholar
  38. 38.
    Showell MG, Brown J, Yazdani A, Stankiewicz MT, Hart RJ. Antioxidants for male subfertility. Cochrane Database Syst Rev 2011, Issue 1. Art. No.: CD007411. DOI:  10.1002/14651858.CD007411.pub2
  39. 39.
    Tremellen K, Miari G, Froiland D, Thompson J. A randomised control trial examining the effect of an antioxidant (Menevit) on pregnancy outcome during IVF-ICSI treatment. Aust N Z J Obstet Gynaecol. 2007;47(3):216–21.PubMedCrossRefGoogle Scholar
  40. 40.
    Tulsiani DR. Carbohydrates mediate sperm-ovum adhesion and triggering of the acrosome reaction. Asian J Androl. 2000;2:87–97.PubMedGoogle Scholar
  41. 41.
    Wathes DC, Abayasekara DR, Aitken RJ. Polyunsaturated fatty acids in male and female reproduction. Biol Reprod. 2007;77(2):190–201.PubMedCrossRefGoogle Scholar
  42. 42.
    WHO laboratory manual for the examination and processing of human semen. Fourth edition. 1999.Google Scholar
  43. 43.
    Wolff H, Politch JA, Martinez A, Haimovici F, Hill JA, Anderson DJ. Leukocytospermia is associated with poor semen quality. Fertil Steril. 1990;53(3):528–36.PubMedGoogle Scholar
  44. 44.
    Zegers-Hochschild F, Adamson GD, de Mouzon J, Ishihara O, Mansour R, Nygren K, et al. The International Committee for Monitoring Assisted Reproductive Technology (ICMART) and the World Health Organization (WHO) Revised Glossary on ART Terminology, 2009.Google Scholar

Copyright information

© Springer Science+Business Media New York 2013

Authors and Affiliations

  • Rafael Lafuente
    • 1
  • Mireia González-Comadrán
    • 3
  • Ivan Solà
    • 4
    • 5
  • Gemma López
    • 1
  • Mario Brassesco
    • 2
  • Ramón Carreras
    • 3
  • Miguel A. Checa
    • 3
  1. 1.Andrology LaboratoryCIRH. Clínica Corachan. ANACERBarcelonaSpain
  2. 2.Medical DepartmentCIRH. Clínica Corachan. ANACERBarcelonaSpain
  3. 3.Department of Obstetrics and GynecologyHospital del MarBarcelonaSpain
  4. 4.Iberoamerican Cochrane Centre, Institute of Biomedical ResearchIIB Sant PauBarcelonaSpain
  5. 5.CIBER de Epidemiología y Salud Pública (CIBERESP)BarcelonaSpain

Personalised recommendations